|
|
|
Insider
Information: |
Hearne Michael S |
Relationship: |
Chief Financial Officer |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
2,620 |
|
Indirect Shares
|
12,767,435 |
|
|
Direct
Value |
$7,465,690 |
|
|
Indirect Value
|
$36,380,806,033 |
|
|
Total
Shares |
12,770,055 |
|
|
Total
Value |
$36,388,271,723 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
20
|
3
|
Stock
price went up :
|
10
|
0
|
Stock
price went down : |
10
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
-17.1%
|
-97.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Odonate Therapeutics Inc |
ODT |
Chief Financial Officer |
2021-03-15 |
2,620 |
2021-11-19 |
12,767,435 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Chief Financial Officer |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-01-29 |
4 |
A |
$19.64 |
$609 |
D/D |
31 |
2,521 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-01-29 |
4 |
A |
$5.20 |
$614 |
D/D |
118 |
2,689 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-02-12 |
4 |
A |
$21.19 |
$593 |
D/D |
28 |
2,549 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-02-12 |
4 |
A |
$5.70 |
$3,051 |
D/D |
535 |
3,224 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-02-26 |
4 |
A |
$17.89 |
$608 |
D/D |
34 |
2,583 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-02-26 |
4 |
A |
$4.45 |
$619 |
D/D |
139 |
3,363 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-03-15 |
4 |
A |
$4.85 |
$616 |
D/D |
127 |
3,490 |
0 |
- |
|
ODT |
Odonate Therapeutics Inc |
Chief Financial Officer |
|
2021-03-15 |
4 |
A |
$16.22 |
$600 |
D/D |
37 |
2,620 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-03-31 |
4 |
A |
$3.60 |
$620 |
D/D |
172 |
3,662 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-04-15 |
4 |
A |
$3.55 |
$615 |
D/D |
173 |
3,835 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-04-30 |
4 |
A |
$3.77 |
$615 |
D/D |
163 |
3,572 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-14 |
4 |
A |
$3.20 |
$617 |
D/D |
193 |
3,765 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-24 |
4 |
B |
$3.68 |
$384,234 |
I/I |
104,403 |
9,509,893 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-25 |
4 |
B |
$3.77 |
$482,734 |
I/I |
127,379 |
9,637,272 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-26 |
4 |
B |
$4.26 |
$710,763 |
I/I |
166,932 |
9,804,204 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-27 |
4 |
B |
$4.47 |
$831,762 |
I/I |
185,928 |
9,990,132 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-05-28 |
4 |
A |
$3.66 |
$618 |
D/D |
169 |
3,934 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-06-01 |
4 |
B |
$4.29 |
$263,931 |
I/I |
59,092 |
10,049,224 |
1.99 |
% |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-06-15 |
4 |
A |
$4.17 |
$616 |
D/D |
148 |
4,082 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-07-15 |
4 |
A |
$3.20 |
$617 |
D/D |
193 |
4,445 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-07-30 |
4 |
A |
$3.07 |
$617 |
D/D |
201 |
4,646 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-09-15 |
4 |
A |
$3.39 |
$1,852 |
D/D |
546 |
5,192 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-09-30 |
4 |
A |
$3.39 |
$617 |
D/D |
182 |
5,374 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-10-15 |
4 |
A |
$3.37 |
$616 |
D/D |
183 |
5,557 |
0 |
- |
|
LJPC |
La Jolla Pharmaceutical C... |
Chief Financial Officer |
|
2021-10-29 |
4 |
A |
$3.42 |
$618 |
D/D |
181 |
5,738 |
0 |
- |
|
145 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|